Clinical Trials Directory

Trials / Sponsors / Soligenix

Soligenix

Industry · 11 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingConfirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL
CTCL/ Mycosis Fungoides, CTCL, Mycosis Fungoides
Phase 32025-01-07
CompletedDusquetide for the Treatment of Behcet's Disease
Behçet Disease
Phase 22024-11-18
CompletedHyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL
Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Phase 22023-12-05
CompletedTopical SGX302 for Mild-to-Moderate Psoriasis
Psoriasis, Plaque Psoriasis, Psoriasis Vulgaris
Phase 22022-12-14
CompletedPK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma
Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Phase 22022-05-09
CompletedDOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Th
Squamous Cell Carcinoma of the Oral Cavity and Oropharynx, Oral Mucositis
Phase 32017-12-04
CompletedFLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) f
Cutaneous T-Cell Lymphoma
Phase 32015-12-01
TerminatedStudy of orBec® as Monotherapy in the Treatment of Patients With Upper GI Symptoms Caused by Chronic Graft Ver
Chronic Gastrointestinal Graft vs Host Disease
Phase 22013-12-01
CompletedA Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer
Oral Mucositis
Phase 22013-12-01
CompletedA Dose Ranging Study of Delayed Release Beclomethasone for Prevention of Acute Enteritis in Patients With Rect
Enteritis
Phase 1 / Phase 22009-12-01
TerminatedStudy of orBec® With Prednisone Therapy in the Treatment of Patients With Graft Versus Host Disease (GVHD)
Acute Gastrointestinal Graft vs Host Disease
Phase 32009-10-01